WNT3A and esophageal squamous cell carcinoma: The 2-bromopalmitate (2-BP), a palmitoylation inhibitor, significantly inhibited the Wnt3A palmitoylation of ESCC cells in a time-dependent manner (0 h, 6 h,12 h) (Figure 6(b)).